Skip to content

Clinical trials

Completed Phase 2 Graft vs Host Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 2 Status: Completed Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20011
20027
20036
20049
20059
20067
20074
20087
20094
20104
20115
20125
20136
20144
20153
20169
20173
20185
20194
20203
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed125

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)13
Dana-Farber Cancer Institute8
Fred Hutchinson Cancer Center8
M.D. Anderson Cancer Center6
University of Michigan Rogel Cancer Center5
H. Lee Moffitt Cancer Center and Research Institute4
National Cancer Institute (NCI)4
Roswell Park Cancer Institute4
Stanford University4
City of Hope Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease125
Precursor Cell Lymphoblastic Leukemia-Lymphoma28
Myelodysplastic Syndromes27
Leukemia26
Leukemia, Myeloid, Acute26
Leukemia, Lymphocytic, Chronic, B-Cell22
Lymphoma, Non-Hodgkin22
Hematologic Neoplasms19
Hodgkin Disease18
Leukemia, Myelogenous, Chronic, BCR-ABL Positive16

Trials

Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.